Publication View

Rising Awareness about the Diseases coupled with Increase in Health Care Spending is Expected to Fuel the Diagnostic and Pathology Laboratory Market in India: Ken Research
Upcoming on January 2017

Indian Diagnostic and pathology Laboratory market is one of the fastest growing market in the country. Several factors such as rise in health care spending, awareness of health related concerns, high prevalence of diseases, increase incidences of lifestyle diseases and penetration of health care insurance are acting as drivers for the market.

In present scenario, market players operate in this market through three business models including single laboratory model, multiple laboratory model and partnered laboratory model. In addition to this, the government owned laboratories are also operating in the market. Consequently, the market could be recorded as fragmented in nature with large number of players in the market. However, intensified competition is observed among major four players-SRL, Thyrocare, Dr. Lal Path, and Metropolis.

On the basis of the tests performed by these laboratories, the overall India diagnostic and pathology laboratory market has been segmented into radiology and pathology tests by test type. These test types are further segmented on the basis of type of test and source for tests. By source of test, pathology tests have been segmented into blood, urine, stool, and body tissue.

The upcoming report is currently available for pre-order and will be published in the month of January 2017. For more information on the coverage, approach and timeline, send us your query at query@kenresearch.com

 

Tentative Scope-India Diagnostic and Pathology Laboratory Market

  1. Executive Summary
  2. Research Methodology

2.1. Market Definitions

2.2. Abbreviations

2.3. Market Size and Modeling

2.4. Limitations

  1. India Diagnostic and Pathology Laboratory Market Size and Growth

3.1.    By Revenue, FY’2011-FY’2016

3.2.    By Number of Tests and Number of Labs, FY’2011-FY’2016

  1. India Diagnostic and Pathology Laboratory Market Segmentation

4.1.    By Pathology and Radiology Tests, FY’2011 - FY’2016

4.2.    By Hospital-based Diagnostic Laboratories, Polyclinics and Independent Diagnostic Laboratories

4.3.    By Region/ Zones (South, North, West, East, and Central)

4.4.    By Tier I, Tier II, and Tier III Cities (Cover top 5 cities)

4.5.    By Organized and Unorganized Players

4.6.    By Government and Privately Owned Diagnostic and Pathology Laboratories

  1. Snapshot on India Pathology Tests Market

5.1.    Market Size by Revenue, FY’ 2016

5.2.    Market Segmentation

5.2.1. By Type of Pathology (Clinical Pathology,Clinical microbiology,Hematology and Homeostasis,Molecular Diagnostics, Surgical Pathology)

5.2.2.  By Source of Test (Blood, Urine, Stool, and Body Tissue)

5.3.    Market Share of Major Players in Pathology Test (by Revenue or by number of test), FY’2016

  1. Snapshot on India Radiology Tests Market

6.1.    Market Size by Revenue, FY’ 2016

6.2.    Market Segmentation

6.2.1. By Type of Test (X-Ray, Ultrasound, ECG, EEG, MRI, Mammography, and Others)

6.3.    Market Share of Major Players in Radiology Test (by Revenue or by number of test), FY’2016

  1. Decision Making Process Before Customer chooses Diagnostic Laboratories (Discuss about Consumer Pain Points and How diagnostic laboratories are catering to it)
  2. Trends and Developments in India Diagnostic and Pathology Laboratory Market- Mergers and Acquisitions and VC and PE Fund Raise (Transaction Announced Date, Target, Acquirer, Stake Diluted, Deal Value, Revenue, EV/Revenue)
  3. Investment Model - Diagnostic and Pathology Laboratory in India (Capital Requirement, ROI, Payback)
  4. Regulatory Environment for India Diagnostic and Pathology Laboratory Market – Documents required to start a centre, Test/ compliance required, subsidy/ tax imposed.
  5. Value Chain Analysis of India Diagnostic and Pathology Laboratory Market –refurbished devices, margin involved
  6. PORTER’S Five Forces Analysis of India Diagnostic and Pathology Laboratory Market
  7. BCG Matrix
  8. Company Profile of India Diagnostic and Pathology Laboratory Market (Cover Average Number of Tests, Number of Tests by Type, Number of Centers, Number of Locations, Revenue and Profit per Center, Major Tests, Average Ticket Size, Revenue Split by Health Packages, Investment per Center, Number of Clinicians, Ratio of Home:Test Clinic Center, USP, Company Overview, Strategies, Number of Employees, Franchise/Own Center Setup Route, Available Diagnostic Medical Equipment and Devices and number of other parameters)
  9. India Diagnostic and Pathology Laboratory Market Future Outlook and Projections, FY’2017-FY’2021

15.1.India Diagnostic and Pathology Laboratory Market by Revenue , FY’ 2017-FY’2021

15.2.Future Analysis by Segmentation

15.3.Cause and Effect Relationship

15.4.Analyst Recommendations – Prerequisites to market entry

  1. Macroeconomic Variables affecting India Diagnostic and Pathology Laboratory Market

16.1.Prevalence of diseases, FY’2011 –FY’2020

16.2.Average Diagnostic spending in India , FY’2011 –FY’2020

16.3.Number of radiologists and Clinicians in India, FY’2011 –FY’2020

16.4.Expenditure of Government on Diagnostics Infrastructure in India, FY’2011 –FY’2020


Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com